Evidence map›Paper›PMID 36166020›Full record

GuidelineJAMA2022

Screening for Syphilis Infection in Nonpregnant Adolescents and Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement.

US Preventive Services Task Force, Carol M Mangione, Michael J Barry, Wanda K Nicholson, Michael Cabana, David Chelmow, Tumaini Rucker Coker, Esa M Davis, Katrina E Donahue, Carlos Roberto Jaén and 7 more

Open access · bronzeAbstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in JAMA, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Clearance ofEClinicalMedicine · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Syphilis Screening and Treatment at a Large Urban Jail.Sexually transmitted diseases · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 1 country.

US Preventive Services Task Force
Carol M MangioneUniversity of California, Los Angeles.
Michael J BarryHarvard Medical School, Boston, Massachusetts.
Wanda K NicholsonUniversity of North Carolina at Chapel Hill.
Michael CabanaAlbert Einstein College of Medicine, New York, New York.
David ChelmowVirginia Commonwealth University, Richmond.
Tumaini Rucker CokerUniversity of Washington, Seattle.
Esa M DavisUniversity of Pittsburgh, Pittsburgh, Pennsylvania.
Katrina E DonahueUniversity of North Carolina at Chapel Hill.
Carlos Roberto JaénThe University of Texas Health Science Center, San Antonio.
Martha KubikGeorge Mason University, Fairfax, Virginia.
Li LiUniversity of Virginia, Charlottesville.
Gbenga OgedegbeNew York University, New York, New York.
Lori PbertUniversity of Massachusetts Medical School, Worcester.
John M RuizUniversity of Arizona, Tucson.
James StevermerUniversity of Missouri, Columbia.
John B WongTufts University School of Medicine, Boston, Massachusetts.
University of North Carolina at Chapel Hill · USGeorge Mason University · USTufts University · USUniversity of Arizona · USAlbert Einstein College of Medicine · USHarvard University · USUniversity of California, Los Angeles · USUniversity of Massachusetts Chan Medical School · USUniversity of Pittsburgh · USUniversity of Virginia · USVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Syphilis is a sexually transmitted infection that can progress through different stages (primary, secondary, latent, and tertiary) and cause serious health problems if left untreated. Reported cases of primary and secondary syphilis in the US increased from a record low of 2.1 cases per 100 000 population in 2000 and 2001 to 11.9 cases per 100 000 population in 2019. Men account for the majority of cases (83% of primary and secondary syphilis cases in 2019), and rates among women nearly tripled from 2015 to 2019. Objective: To reaffirm its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a reaffirmation evidence update focusing on targeted key questions evaluating the performance of risk assessment tools and the benefits and harms of screening for syphilis in nonpregnant adolescents and adults. Population: Asymptomatic, nonpregnant adolescents and adults who have ever been sexually active and are at increased risk for syphilis infection. Evidence Assessment: Using a reaffirmation process, the USPSTF concludes with high certainty that there is a substantial net benefit of screening for syphilis infection in nonpregnant persons who are at increased risk for infection. Recommendation: The USPSTF recommends screening for syphilis infection in persons who are at increased risk for infection. (A recommendation).

Indexed as

Mass ScreeningSyphilisAdolescentAdultAdvisory CommitteesFemaleHumansMalePreventive Health ServicesSexually Transmitted DiseasesUnited States

Identifiers

PMID36166020
OpenAlexW4297252808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.